House of Lords Business
Show full summary

Lord Hunt of Kings Heath to ask His Majesty's Government, further to the Written Answer by Lord Markham on 9 February (HL5209), why the Gloucestershire Integrated Care Board continues to re-review liothyronine patients already assessed in the NHS despite national guidance that “patients who have already had a review by an NHS consultant endocrinologist should continue to be prescribed liothyronine under existing arrangements”. 

Question HL354: tabled on 15 November 2023 and due for answer by 29 November 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask His Majesty's Government, further to the Written Answer by Lord Markham on 9 February (HL5209), why the Gloucestershire Integrated Care Board continues to re-review liothyronine patients already assessed in the NHS despite national guidance that “patients who have already had a review by an NHS consultant endocrinologist should continue to be prescribed liothyronine under existing arrangements”.  HL354
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Date Answered

Monday 27 November 2023

Member's Registered Interests

There are no interests to show.

Main Member

Lord Hunt of Kings Heath
Labour
Life peer